SOCIETY PASS INCORPORATED. (SOPA): Nasdaq/NYSE listing notice — Nasdaq panel grants Society Pass extension to June 30, 2025 to regain equity compliance

SOCIETY PASS INCORPORATED.

Received delisting notice Feb 18, 2025 for failing to maintain $2.5M stockholders' equity (Rule 5550(b)(2)).
April 1, 2025 hearing; Panel granted exception until June 30, 2025 based on presented compliance plan.
Condition: company must file an 8-K describing transactions to achieve and demonstrate long-term equity compliance.
Stock remains listed on Nasdaq during extension period subject to meeting conditions.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

SOCIETY PASS INCORPORATED. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)(2)

Exact text from the filing

April 9, 2025, the Panel issued a decision that granted the Company’s request to continue its listing on Nasdaq based on the information presented. The Panel has determined to grant the Company’s request for an exception until June 30, 2025 (the “Extension Period”). The compliance plan was conditioned on (i) the Company filing a Form 8-K describing the transactions undertaken by the Company to achieve compliance and demonstrate long-term compliance with the Equity Rule, and by providing an indication of its equity following those transactions; and (ii) the Company will evidence compliance with

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SOCIETY PASS INCORPORATED. filing history →

Source: SEC EDGAR

accession 0001213900-25-031319

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.